PHILIPP HAAS - CHAIRMAN & CEO MESUT CETIN - DIRECTOR & CFO
2
USD / TRY Exchange RateThe period end USD/TRY exchange rate increased by 0.93%; 3.5192 as of 31 December 2016, 3.5521 as of 30 September 2017.
The average USD/TRY exchange rate strengthened by 22.6%; 2.9309 for
3.6386
3.5521
3.5192
3.5071
2.9959
Average USD/TRY3.8
3.6
3.4
3.2
3.0
2.8
2.6
2.4
2.2
2.0
3.6356
3.5936
2.9309
9M 2016, 3.5936 for 9M 2017.
3.6928
3.8
3.6
3.4
3.2
3.0
2.8
2.6
2.4
2.2
2.0
2.9409
2.9181
2
3
EastPharma Sales Performance (IFRS) - 30.09.2017Revenues in 9M 2017 reached to US$ 163.5mn (TRY 588.3mn) vs US$
172.6mn (TRY 505.4mn) in 9M 2016.
5.3% year-on-year decrease in US$
16.4% year-on-year increase in TRY
Revenues : ($, mn)
209.9
224.9
172.6
163.5
2015
2016
9M'16
9M'17
3
4
EastPharma Sales Performance (IFRS) - 30.09.2017 Revenues Breakdown:Human Pharma Veterinary Goods Other
6.3%
1.2%
92.5%
Domestic Sales
Export Sales
6.9%
93.1%
4
Eastpharma Ltd. published this content on 03 November 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 03 November 2017 11:23:25 UTC.
Original documenthttp://www.eastpharmaltd.com/assets/file/EP%20DEVA%209M%202017%20IRCall.pdf
Public permalinkhttp://www.publicnow.com/view/B6ABBC398C65893D6F62100717D678471D75FA97